5 High Growth Large Cap Stocks to Invest In

3. argenx SE (NASDAQ:ARGX)

Q/Q Sales Growth: 1,986%

Number of Hedge Fund Holders in Q3 2022: 36

argenx SE (NASDAQ:ARGX) is a biotechnology company that develops treatments for diseases such as myopathy and cancer. The firm is headquartered in Breda, the Netherlands.

argenx SE (NASDAQ:ARGX)’s fiscal third quarter which ended in September 2022 saw the firm report $146 million in revenue, which marked a 1,986% annual growth. 36 of the 920 hedge funds part of Insider Monkey’s Q3 2022 study had held a stake in the firm.

argenx SE (NASDAQ:ARGX)’s largest investor is Kurt Von Emster’s VenBio Select Advisor which owns 1.2 million shares that are worth $479 million.

Follow Argenx Se (NASDAQ:ARGX)